The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability

Radiotherapy and Oncology

Volumn 50, Issue 1, 1999, Pages 67-75

  Mackay, R I ^a   Hendry, J H ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Cellular radiosensitivity; Inherent variability; Radiotherapy

Indexed keywords

ARTICLE; CANCER RADIOTHERAPY; DOSE CALCULATION; FIBROBLAST; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY;

ALGORITHMS; CELL DIVISION; CELL SURVIVAL; COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; FIBROBLASTS; FORECASTING; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; POISSON DISTRIBUTION; PROBABILITY; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE;

EID: 0033019262     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(98)00132-7     Document Type: Article

References (29)

1. Anscher MS, Kong FM, Marks LB, Bentel GC, Jirtle RL. Changes in plasma transforming growth factor beta during radiotherapy and the risk of symptomatic radiation-induced pneumonitis. Int. J. Radiat. Oncol. Biol. Phys. 1997;37:253-258.
2. Arlett CF, Green MH, Priestley A, Harcourt SA, Mayne LV. Comparative human cellular radiosensitivity: I. The effect of SV40 transformation and immortalisation on the gamma-irradiation survival of skin derived fibroblasts from normal individuals and from ataxia-telangiectasia patients and heterozygotes. Int. J. Radiat. Biol. 1988;54:911-928.
3. Bentzen SM. Steepness of the clinical dose-control curve and variation in the in vitro radiosensitivity of head and neck squamous cell carcinoma. Int. J. Radiat. Biol. 1992;61:417-423.
4. Bentzen SM. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing. Radiother. Oncol 1997;43:121-131.
5. Bentzen SM, Tucker SL. Quantifying the position and steepness of dose response curves. Int. J. Radiat. Biol. 1997;7:531-542.
6. Bentzen SM. Radiobiological considerations in the design of clinical trials. Radiother. Oncol. 1994;32:1-11.
7. Bentzen SM, Tucker SL. Individualisation of radiotherapy dose prescriptions by means of an in vitro radiosensitivity assay. Radiother. Oncol 1998;46:216-218.
8. Bentzen SM, Overgaard M. Relationship between and late normal tissue injury after postmastectomy radiotherapy. Radiother. Oncol 1991;20:159-165.
9. Bentzen SM, Overgaard M, Overgaard J. Clinical correlations between late normal-tissue endpoints after radiotherapy: Implications for predictive assays of radiosensitivity. Eur. J. Cance 1993;29A:1373-1376.
10. Bernier J, Thames HD, Smith CD, Horiot JC. Tumor response, mucosal reactions and late effects after conventional and hyperfractionated radiotherapy. Radiother. Oncol. 1998;47:137-143.
11. Brock WA, Tucker SL, Geara FB, et al. Fibroblast radiosensitivity versus acute and late normal skin responses in patients treated for breast cancer. Int. J. Radiat. Oncol. Biol. Phys. 1995;32:1371-1379.
12. Burnet NG, Nyman J, Turesson I, Wurm R, Yarnold JR, Peacock JH. The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules. Radiother. Oncol. 1994;33:228-238.
13. Burnet NG, Wurm R, Peacock JH. Low dose-rate fibroblast radiosensitivity and the prediction of patient response to radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1996;70:289-300.
14. Cox R, Masson WK. Radiosensitivity in cultured human fibroblasts. Int. J. Radiat. Biol. 1980;38:575-576.
15. Peters LJ, Ang KK, et al. Comparison between normal tissue reactions and local tumour control in head and neck cancer patients treated by definitive radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 1996;35:455-462.
16. Geara FB, Peters LJ, Ang KK, Wike JL, Brock WA. Prospective comparison of in vitro normal cell radiosensitivity and normal tissue reactions in radiotherapy patients. Int. J. Radiat. Oncol. Biol. Phys. 1993;27:1173-1179.
17. Geara FB, Peters LJ, Ang KK, et al. Intrinsic radiosensitivity of normal human fibroblasts and lymphocytes after high- and low-dose-rate irradiation. Cancer Res. 1992;52:6348-6352.
18. Hendry JH. Treatment acceleration in radiotherapy: The relative time factors and dose-response slopes for tumours and normal tissues. Radiother. Oncol 1992;25:308-312.
19. Hendry JH. Biological response modifiers and normal tissue injury after irradiation. Semin. Rad. Oncol 1994;4:123-132.
20. Johansen J, Bentzen SM, Overgaard J, Overgaard M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia and skin erythema after radiotherapy. Radiother. Oncol. 1996;40:101-109.
21. Johansen J, Bentzen SM, Overgaard J, Overgaard M. Evidence for a positive correlation between in vitro radiosensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int. J. Radiat. Biol. 1994;66:407-412.
22. Little JB, Nove J, Strong LC, Nichols WW. Survival of human diploid skin fibroblasts from normal individuals after X-irradiation. Int. J. Radiat. Biol 1988;54:899-910.
23. MacKay RI, Niemierko A, Goitein M, Hendry JH. Potential clinical impact of normal tissue intrinsic radiosensitivity testing (letter). Radiother. Oncol 1998;46:215-216.
24. Millar WT, Hendry JH. Haemopoietic injury after irradiation: Analysis of dose responses and repair using a target-cell model. Int. J. Radiat. Biol 1997;72:561-573.
25. Norman A, Kagan AR, Chan SL. The importance of genetics for the optimization of radiation therapy: A hypothesis. Am. J. Clin. Oncol. 1988;11:84-88.
26. Thames HD, Schultheiss TE, Hendry JH, Tucker SL, Dubray BM, Brock WA. Can modest escalations of dose be detected as increased tumor control? Int. J. Radiat. Oncol. Biol. Phys. 1992;22:241-246.
27. Tucker SL, Geara FB, Peters LJ, Brock WA. How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity? Radiother. Oncol. 1996;38:103-113.
28. West CML. Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br. J. Radiol. 1995;68:827-837.
29. West CML, Hendry JH. Intrinsic radiosensitivity as a predictor of patient response to radiotherapy. Br. J. Radiol. Suppl. 1992;24:146-152.